A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer
- Resource Type
- Academic Journal
- Source
- Japanese Journal of Clinical Oncology. Nov 01, 2017 47(11):1002-1009
- Subject
- Language
- English
- ISSN
- 0368-2811